How Cancer Chemotherapy Works
Chemotherapy targets rapidly dividing cells — which is why it affects cancer, but also hair follicles and the gut lining. This guide explains the major chemotherapy drug classes, why side effects occur, and what clinical trials revealed about how these drugs are used today.
Cancer and Cell Division
Cancer is fundamentally a disease of uncontrolled cell division. Normal cells divide in a carefully regulated cycle — growing, copying their DNA, and splitting into two daughter cells — then stop or die as programmed. Cancer cells have mutations that allow them to bypass these controls, dividing continuously and spreading.
Traditional chemotherapy exploits one characteristic that most cancer cells share: they divide more rapidly than most normal cells. By targeting processes required for cell division, chemotherapy can preferentially kill cancer cells — though not exclusively. The impact on rapidly dividing normal cells is the source of many side effects.
Alkylating Agents: Damaging DNA
Alkylating agents were the first class of chemotherapy drugs, discovered when nitrogen mustard gas (a chemical weapon) was observed to suppress bone marrow during World War II.
These drugs work by chemically attaching (alkylating) bulky chemical groups directly to DNA bases — particularly guanine. This alkylation causes DNA strands to cross-link, preventing the strands from being properly separated during replication. When a cancer cell tries to divide and copy its DNA, the cross-links create lethal breaks.
Examples include:
- Cyclophosphamide: Used in lymphoma, breast cancer, leukemia. A prodrugProdrug A pharmacologically inactive compound that is converted to an active drug inside the body through metabolic processes. Prodrugs are designed to improve absorption, reduce side effects, or target drug
Alkylating agents work across the cell cycle and can damage both dividing and non-dividing cells, making them broadly active but also toxic to resting normal cells.
Antimetabolites: Starving Cancer of Building Blocks
DNA is made of nucleotides — chemical units containing bases (A, T, C, G). Antimetabolites are chemically similar to normal nucleotides or vitamins involved in nucleotide synthesis, and they disrupt DNA and RNA production by competing with or replacing the natural building blocks.
Folate antagonists: Methotrexate mimics folate, inhibiting the enzyme dihydrofolate reductase (DHFR). Without functional DHFR, cells cannot produce thymidine, one of DNA's building blocks. High-dose methotrexate can be rescued with leucovorin (folinic acid), which bypasses the blocked enzyme — a strategy that lets oncologists use very high doses while protecting normal cells.
Pyrimidine antagonists: 5-Fluorouracil (5-FU) is incorporated into RNA and inhibits an enzyme (thymidylate synthase) needed for DNA synthesis. 5-FU is a cornerstone of colorectal and breast cancer treatment. Capecitabine (Xeloda) is an oral prodrug that converts to 5-FU selectively in tumor tissue.
Purine antagonists: Cladribine, fludarabine, and mercaptopurine disrupt purine synthesis. These are mainly used in leukemias and lymphomas.
Mitotic Inhibitors
Cell division requires the cell to physically pull the duplicated chromosomes apart into two daughter cells. This is done by a structure called the mitotic spindle — protein cables made of tubulin.
Vinca alkaloids (vincristine, vinblastine, vinorelbine) are derived from the periwinkle plant. They bind to tubulin and prevent it from polymerizing (assembling) into spindle fibers. Without a functional spindle, chromosomes cannot be separated and the cell dies.
Taxanes (paclitaxel, docetaxel) have the opposite mechanism: they prevent tubulin from depolymerizing. The spindle forms but gets "frozen" — it cannot do the dynamic assembly and disassembly needed to separate chromosomes. The cell cannot complete division and undergoes programmed death.
Taxanes are widely used in breast, lung, ovarian, and prostate cancer.
Topoisomerase Inhibitors
When DNA is being replicated or read, it becomes tangled (supercoiled). Topoisomerase enzymes manage this by temporarily cutting DNA strands, allowing them to unwind, then resealing the cuts.
Topoisomerase I inhibitors (irinotecan, topotecan) trap the topoisomerase-DNA complex in a broken state — the enzyme cuts DNA but cannot reseal it. The result is catastrophic DNA strand breaks.
Topoisomerase II inhibitors — anthracyclines (doxorubicin, daunorubicin, epirubicin) and etoposide — similarly trap topoisomerase II. Anthracyclines are among the most potent anticancer drugs known; they are also cardiotoxic, with cumulative doses above a threshold associated with cardiomyopathy.
Why Side Effects Target Fast-Growing Normal Tissue
Chemotherapy targets dividing cells — but cancer is not the only tissue that divides rapidly. The side effects of chemotherapy are almost entirely explained by which normal tissues also have high cell turnover:
| Normal Tissue | Divides Rapidly? | Chemotherapy Side Effect |
|---|---|---|
| Bone marrow | Yes | Neutropenia, anemia, thrombocytopenia |
| Hair follicles | Yes | Hair loss (alopecia) |
| Gut lining (mucosa) | Yes | Nausea, vomiting, mucositis, diarrhea |
| Reproductive cells | Yes | Infertility |
| Skin | Moderately | Rash, nail changes |
Nerve cells, by contrast, divide very little — yet cisplatin and taxanes cause peripheral neuropathy (numbness and tingling) through a different mechanism (direct toxicity to the myelin sheath).
Targeted Therapy vs. Traditional Chemotherapy
A major advance since the 1990s has been the development of targeted therapies — drugs designed to hit specific molecular abnormalities present in cancer cells but not (or minimally) in normal cells.
- Imatinib (Gleevec): Targets the BCR-ABL fusion protein produced by the Philadelphia chromosome in CML (chronic myeloid leukemia). Transformed CML from a disease requiring bone marrow transplant to one managed with a daily pill.
- Trastuzumab (Herceptin): Targets HER2, a growth factor receptor overexpressed in some breast and gastric cancers.
- EGFR inhibitors (erlotinib, gefitinib): Target the epidermal growth factor receptor mutated in some lung cancers.
Targeted therapies have narrower side-effect profiles because they don't broadly attack dividing cells — but they work only when the target is present. Genetic testing (tumor profiling) is increasingly standard to identify which targets are present before selecting therapy.
Clinical Trials and Adverse Drug Reactions
The standard doses and regimens used in oncology today were established through decades of clinical trials — prospective studies that tested drugs in cancer patients and systematically documented both responses and adverse drug reactions (ADRs).
Clinical trial phasesClinical Trial Phases The sequential stages of testing a new drug in humans. Phase I tests safety in 20-100 healthy volunteers. Phase II tests efficacyEfficacy The maximum therapeutic effect a drug can produce, regardless of the dose given. A drug with higher efficacy can achieve a greater maximum response than one with lower efficacy, even if the latter is
Chemotherapy has some of the most serious ADRs of any drug classDrug Class A group of medications that share a similar chemical structure, mechanism of action, or therapeutic use. Drugs within the same class often have similar effects, side effects, and drug interactions, th
Key Takeaways
- Chemotherapy targets rapidly dividing cells; alkylating agents damage DNA directly, antimetabolites starve cells of building blocks, mitotic inhibitors freeze or prevent the spindle, and topoisomerase inhibitors cause irreparable DNA breaks.
- Side effects occur in normal tissues that also divide rapidly — bone marrow, hair follicles, and the gut lining are the most affected.
- Targeted therapies exploit specific molecular mutations in cancer cells, offering more precise treatment with narrower side-effect profiles than traditional chemotherapy.
- Chemotherapy regimens are established through phased clinical trials that systematically document adverse drug reactions against efficacy.
- Cardiotoxicity (anthracyclines), peripheral neuropathy (platinum drugs, taxanes), and secondary malignancies are among the most serious long-term chemotherapy adverse effects.